Bootmaker Dr Martens' margin warning knocks shares down 20%

BRITISH bootmaker Dr Martens has warned of a sharp hit to profit margins due to weaker than expected demand ahead of the key Christmas season, increased investments and the strong dollar, sending its shares down some 20 per cent.

Chief executive Kenny Wilson told Reuters the next few weeks leading up to Christmas would be crucial, but he was confident of meeting demand for its boots as the company’s inventory is better stocked than last year.

“Going into the winter season, we see people buying more of our iconic boots which (are) ... the 1460s and our Jadons,” he added.

The group said it expects its core earnings margin for the full year to be between 100 basis points and 250 basis points lower than last year, though it did not give a total net figure.

The maker of the clunky 1460 boots with yellow stitching said it sold about 6.3 million pairs of shoes in the six months ended Sep 30, up 400,000 from last year and a record level.

Dr Martens, whose pricey work boots have been fashion items since the 60s after being favoured by the likes of Who guitarist Pete Townshend, said demand was still growing, suggesting customers are still restocking their wardrobes to keep pace with the return of social events post-pandemic.

To help employees cope with rising prices and higher bills, the company has offered a one-off payment of £500 (S$833) for employees earning less than £45,000 a year, Wilson said.

First-half core profit was flat, compared with a strong year-ago period, the company said. Revenue rose 13 per cent to £418.6 million, helped by price hikes. The interim dividend was raised 28 per cent to 1.56 pence.

The stock was down 21.2 per cent at 225.6 pence in late-morning trading in London, having risen the previous session to its highest since February. REUTERS


BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to